Abstract:Lipoprotein apheresis (LDL-a) is an important adjuvant therapy for patients with familial hypercholesterolemia and those intolerant with high-dose statin. However, the application of clinically available LDL-a techniques is currently restricted in China because of their high cost and technical complicacy. Recently, a large number of researchers have focused on the development of novel low-density lipoprotein sorbents to replace the existing LDL-a techniques. In this review, the state-of-the-art on the application of diverse LDL-a techniques in patients with familial hypercholesterolemia was first summarized, and the advantages and disadvantages of these techniques were compared. Then, the recent advances in developing novellow-density lipoprotein sorbents were discussed,and the lipoprotein adsorption efficacy and biocompatibility of immune-, anion-, and hydrophobic- as well as amphipathic- low-density lipoprotein sorbents were compared. Meanwhile, challenges and perspectives for the continuous development of low-density lipoprotein sorbents were also addressed.